Your browser doesn't support javascript.
loading
Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.
Mencacci, Niccolò E; Isaias, Ioannis U; Reich, Martin M; Ganos, Christos; Plagnol, Vincent; Polke, James M; Bras, Jose; Hersheson, Joshua; Stamelou, Maria; Pittman, Alan M; Noyce, Alastair J; Mok, Kin Y; Opladen, Thomas; Kunstmann, Erdmute; Hodecker, Sybille; Münchau, Alexander; Volkmann, Jens; Samnick, Samuel; Sidle, Katie; Nanji, Tina; Sweeney, Mary G; Houlden, Henry; Batla, Amit; Zecchinelli, Anna L; Pezzoli, Gianni; Marotta, Giorgio; Lees, Andrew; Alegria, Paulo; Krack, Paul; Cormier-Dequaire, Florence; Lesage, Suzanne; Brice, Alexis; Heutink, Peter; Gasser, Thomas; Lubbe, Steven J; Morris, Huw R; Taba, Pille; Koks, Sulev; Majounie, Elisa; Raphael Gibbs, J; Singleton, Andrew; Hardy, John; Klebe, Stephan; Bhatia, Kailash P; Wood, Nicholas W.
  • Mencacci NE; 1 Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK2 IRCCS Istituto Auxologico Italiano, Department of Neurology and Laboratory of Neuroscience - Department of Pathophysiology and Transplantation, "Dino Ferrari" Centre, Università degli Studi di Milano, 20149 Mila
  • Isaias IU; 3 Department of Neurology, University Hospital, 97080 Würzburg, Germany4 Parkinson Institute, Istituti Clinici di Perfezionamento, 20126 Milan, Italy.
  • Reich MM; 3 Department of Neurology, University Hospital, 97080 Würzburg, Germany.
  • Ganos C; 5 Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, London WC1N 3BG, UK6 Department of Neurology, University Medical Centre Hamburg-Eppendorf, 20246 Hamburg, Germany7 Department of Paediatric and Adult Movement Disorders and Neuropsychiatry, Institute of Neu
  • Plagnol V; 8 UCL Genetics Institute, London WC1E 6BT, UK.
  • Polke JM; 9 Neurogenetics Unit, National Hospital for Neurology and Neurosurgery, London WC1N 3BG, UK.
  • Bras J; 1 Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK.
  • Hersheson J; 1 Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK.
  • Stamelou M; 5 Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, London WC1N 3BG, UK10 Neurology Clinic, Attiko Hospital, University of Athens, 126 42 Haidari, Athens, Greece11 Neurology Clinic, Philipps University, 35032 Marburg, Germany.
  • Pittman AM; 1 Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK12 Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, London WC1N 3BG, UK.
  • Noyce AJ; 1 Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK12 Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, London WC1N 3BG, UK.
  • Mok KY; 1 Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK.
  • Opladen T; 13 Division of Inborn Errors of Metabolism, University Children's Hospital Heidelberg, 69120 Heidelberg, Germany.
  • Kunstmann E; 14 Institut of Human Genetics, Julius-Maximilian-University, 97070 Würzburg, Germany.
  • Hodecker S; 6 Department of Neurology, University Medical Centre Hamburg-Eppendorf, 20246 Hamburg, Germany.
  • Münchau A; 7 Department of Paediatric and Adult Movement Disorders and Neuropsychiatry, Institute of Neurogenetics, University of Lübeck, 23538 Lübeck, Germany.
  • Volkmann J; 4 Parkinson Institute, Istituti Clinici di Perfezionamento, 20126 Milan, Italy.
  • Samnick S; 15 Department of Nuclear Medicine, University Hospital, 97080 Würzburg, Germany.
  • Sidle K; 1 Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK.
  • Nanji T; 9 Neurogenetics Unit, National Hospital for Neurology and Neurosurgery, London WC1N 3BG, UK.
  • Sweeney MG; 9 Neurogenetics Unit, National Hospital for Neurology and Neurosurgery, London WC1N 3BG, UK.
  • Houlden H; 1 Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK.
  • Batla A; 5 Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, London WC1N 3BG, UK.
  • Zecchinelli AL; 4 Parkinson Institute, Istituti Clinici di Perfezionamento, 20126 Milan, Italy.
  • Pezzoli G; 4 Parkinson Institute, Istituti Clinici di Perfezionamento, 20126 Milan, Italy.
  • Marotta G; 16 Department of Nuclear Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milano, Italy.
  • Lees A; 12 Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, London WC1N 3BG, UK.
  • Alegria P; 17 Serviço de Neurologia, Hospital Beatriz Ângelo, 2674-514 Loures, Portugal.
  • Krack P; 18 Movement Disorder Unit, CHU Grenoble, Joseph Fourier University, and INSERM U836, Grenoble Institute Neuroscience, F-38043 Grenoble, France.
  • Cormier-Dequaire F; 19 Université Pierre et Marie Curie-Paris6, Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière, UMR-S975; Inserm, U975, Cnrs, UMR 7225, Paris, France20 Centre d'Investigation Clinique (CIC-9503), Département de Neurologie, Hôpital Pitié-Salpétriêre, AP-HP, Paris, France.
  • Lesage S; 19 Université Pierre et Marie Curie-Paris6, Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière, UMR-S975; Inserm, U975, Cnrs, UMR 7225, Paris, France.
  • Brice A; 19 Université Pierre et Marie Curie-Paris6, Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière, UMR-S975; Inserm, U975, Cnrs, UMR 7225, Paris, France21 Département de Génétique et Cytogénétique, Pitié-Salpêtrière hospital, 75013 Paris, France.
  • Heutink P; 22 DZNE-Deutsches Zentrum für Neurodegenerative Erkrankungen (German Centre for Neurodegenerative Diseases), Hertie Institute for Clinical Brain Research, University of Tübingen, 72076 Tübingen, Germany.
  • Gasser T; 22 DZNE-Deutsches Zentrum für Neurodegenerative Erkrankungen (German Centre for Neurodegenerative Diseases), Hertie Institute for Clinical Brain Research, University of Tübingen, 72076 Tübingen, Germany.
  • Lubbe SJ; 23 Department of Clinical Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK.
  • Morris HR; 23 Department of Clinical Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK.
  • Taba P; 24 Department of Neurology and Neurosurgery, University of Tartu, 50090 Tartu, Estonia.
  • Koks S; 25 Department of Pathophysiology, Centre of Excellence for Translational Medicine, University of Tartu, 50411 Tartu, Estonia.
  • Majounie E; 26 Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD 20892, USA.
  • Raphael Gibbs J; 26 Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD 20892, USA.
  • Singleton A; 26 Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD 20892, USA.
  • Hardy J; 1 Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK12 Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, London WC1N 3BG, UK.
  • Klebe S; 3 Department of Neurology, University Hospital, 97080 Würzburg, Germany.
  • Bhatia KP; 5 Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, London WC1N 3BG, UK n.wood@ucl.ac.uk k.bhatia@ucl.ac.uk.
  • Wood NW; 1 Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK n.wood@ucl.ac.uk k.bhatia@ucl.ac.uk.
Brain ; 137(Pt 9): 2480-92, 2014 Sep.
Article en En | MEDLINE | ID: mdl-24993959
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / GTP Ciclohidrolasa / Heterocigoto / Mutación Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged País como asunto: America do norte / Europa Idioma: En Año: 2014 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / GTP Ciclohidrolasa / Heterocigoto / Mutación Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged País como asunto: America do norte / Europa Idioma: En Año: 2014 Tipo del documento: Article